Merck and ISB team to define molecular mechanisms of SARS-CoV-2 infection
KENILWORTH, N.J. — Merck and the Institute for Systems Biology (ISB), announced on Monday a new research collaboration to investigate and define the molecular mechanisms of SARS-CoV-2 infection and COVID-19 and identify targets for medicines and vaccines. Merck has also entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of
